|
US2018318346A1
|
|
Immunomodulatory properties of mapcs and uses thereof
|
|
WO2007094962A2
|
|
Pyrazoles for the treatment of obesity and other cns disorders
|
|
CN101410126A
|
|
MAPC therapeutics without adjunctive immunosuppressive treatment
|
|
NZ706776A
|
|
Mapc therapeutics without adjunctive immunosuppressive treatment
|
|
NZ570614A
|
|
Multipotent adult progenitor cell treatment of brain injuries and diseases
|
|
AU2007207508A1
|
|
Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof
|
|
CN104095878A
|
|
Immunomodulatory properties of multipotent adult progenitor cells and uses thereof
|
|
TW200745091A
|
|
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
|
|
WO2007016485A2
|
|
Use of a gsk-3 inhibitor to maintain potency of cultured cells
|
|
WO2007117262A2
|
|
Culture of non-embryonic cells at high cell density
|
|
CA2594264A1
|
|
4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders
|
|
CN101124207A
|
|
Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
|
|
CA2581338A1
|
|
Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof
|
|
WO2006028961A2
|
|
Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
|
|
KR20130047765A
|
|
Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators
|
|
WO2006014647A2
|
|
Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof
|
|
EP1773345A2
|
|
Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders
|
|
NZ550891A
|
|
Substituted azepine derivatives as serotonin receptor modulators
|
|
WO2005014786A2
|
|
Enhanced engineered chromosome formation from alpha satellite with artificially increased density of cenp-b boxes
|
|
AU2003294241A1
|
|
Methods for using osteocalcin
|
